Skip to main content
Clinical Liver Disease logoLink to Clinical Liver Disease
. 2020 May 7;15(4):136–140. doi: 10.1002/cld.936

Integrating Palliative Care in the Management of Patients With Advanced Liver Disease

Arpan Patel 1,2,, Nneka N Ufere 3
PMCID: PMC7206323  PMID: 32395238

Short abstract

http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2046-2484/video/15-4-reading-patel a video presentation of this article


Abbreviations

ACP

advance care planning

ALD

advanced liver disease

CHF

congestive heart failure

COPD

chronic obstructive pulmonary disease

ESLD

end‐stage liver disease

ESRD

end‐stage renal disease

GCD

goals of care discussion

MND

motor neuron disease

MS

multiple sclerosis

Being diagnosed with an advanced liver disease (ALD), such as decompensated cirrhosis or hepatocellular carcinoma, has a dramatic impact on both life expectancy and quality of life for afflicted individuals.1, 2 Although many scientific achievements in the field of hepatology have led to improved survival in these cohorts of patients, curative options are still unavailable for most.3, 4 Much less attention has been paid to improving the quality of life for these patients, which is expected to be a growing need. Integrating principles of palliative care in the management of patients with ALD may be one way of solving this issue.

What is Palliative Care?

The National Consensus Project Guidelines define palliative care as a “person‐ and family‐centered approach to care, providing people living with serious illness relief from the symptoms and stress of an illness”.5 The ultimate goal of palliative care is to improve quality of life for the patient and the family. Important dimensions of palliative care include: (1) physical symptom management; (2) mental health management; (3) advance care planning (ACP); (4) addressing social and cultural issues; (5) addressing spiritual, religious, and existential issues; and (6) end‐of‐life care. Ideally, it is offered across all practice settings, at any stage of a patient’s illness trajectory, and with the involvement of multiple disciplines.5 It is thus important to recognize that palliative care is not synonymous with end‐of‐life care or hospice (Fig. 1A and 1B).

Figure 1.

Figure 1

(A) Dimensions of palliative care. Adapted from Clinical Practice Guidelines for Quality Palliative Care, 4th ed.5 Copyright 2018, National Coalition for Hospice & Palliative Care. (B) Comparison of the traditional versus contemporary model of palliative care. Reprinted with permission from New England Journal of Medicine.27 Copyright Massachusetts Medical Society.

Depending on the resources available in different health care settings, palliative care can be offered by generalists (without specialty training in palliative care) or specialists (have received training).6 Interdisciplinary teams include not only physicians but also advanced practice registered nurses, physician assistants, nurses, social workers, behavioral health specialists, chaplains, and others based on need.5 Early palliative care involvement has been associated with improvements in patient and caregiver satisfaction, as well as lower health care utilization.7 In fact, results from a high‐quality randomized controlled trial suggest that early palliative care consultation in patients with advanced cancer is associated with better quality of life and mood. The authors of this study hypothesized that this may be due to improvements in coordinated care, self‐advocacy, and social support.8 Benefits in physical and depressive symptoms have also been seen in a smaller, noncontrolled study of patients with ALD who received palliative care consultation during transplant evaluation.9 Multiple subspecialty societies treating patients with advanced cancer, end‐stage renal disease (ESRD), heart failure, chronic obstructive pulmonary disease, and other chronic conditions recommend inclusion of early palliative care as part of their management. Despite this, involvement of specialty palliative for patients with ALD is low.10, 11 In the following paragraphs, we will highlight ACP and symptom management, two particularly unmet needs for palliative care in ALD, and provide strategies for managing these issues in practice or considering specialty referral.

ACP

ACP is the iterative process by which patients and their caregivers clarify, establish, and document their illness and prognostic understanding, personal values and health goals, and preferences for medical care throughout the course of their illness.12 Timely ACP has been associated with a number of positive outcomes for patients, including improved quality of life and satisfaction with care, as well as reduced health care utilization at end of life.13 Unfortunately, ACP occurs infrequently. In a prospective study of outpatients with cirrhosis, only 14% of patients had completed a goals of care designation, and only 33% had identified a surrogate decision‐maker.14 Surveys of clinicians providing care to patients with ALD have identified insufficient clinician communication skills training and limited reimbursement as important barriers to ACP.15, 16

Timely ACP is critically important for patients with ALD. Documenting preferences for medical care (through a health care proxy form, a physician or medical order for life‐sustaining treatment, or a living will) and establishing a surrogate decision‐maker for patients with ALD should occur early in the disease course. Special attention should be given to: (1) patients who are being considered for liver transplant and noncandidates, (2) patients with hepatic encephalopathy, and (3) patients who were previously treated in the intensive care unit or received life‐sustaining treatments.17 Given that acute deteriorations such as variceal bleeding, sepsis, and acute kidney injury are often unpredictable, prior knowledge of patients’ preferences regarding the intensity of care they would like to receive allows clinicians to provide goal‐concordant care.

A number of conceptual frameworks can be used to help guide discussions with patients with ALD. The SPIKES framework, initially developed in the oncology setting, provides a stepwise approach for disclosing difficult news18 (Table 1). Brisebois et al.19 have also published suggested conversation starters for ACP discussions (Table 2). Starting in 2015, Medicare adopted new billing codes to provide reimbursement to clinicians for ACP using Current Procedure Terminology (CPT) codes 99497 and 99498. These provide some incentive for physicians to help integrate ACP into their practice.20 Involvement of specialty palliative care services has also been associated with more frequent goals of care discussions in the intensive care unit setting and greater completion of advance directives in outpatients undergoing liver transplant evaluation, so considering expertise of these teams should strongly be considered.9, 21

Table 1.

The SPIKES Framework for Delivering Bad News18

6‐Step SPIKES Framework
Setting

Setting up the interview

  • Arrange for some privacy.
  • Involve significant others if the patient chooses.
  • Invite other relevant parties: interpreter, social worker, surgeon, palliative care physician.
  • Sit down with the patient.
  • Make a connection and establish rapport with the patient.
  • Manage time constraints and interruptions.
Perception

Assessing the patient’s perception

  • Use open‐ended questions to determine the patient’s level of comprehension about his or her medical condition (i.e., “What have you been told about your medical situation so far?”).
Invitation

Obtaining the patient’s invitation

  • Assess the patient’s readiness to receive information.
  • Discuss information disclosure at the time of ordering studies (i.e., “I have some updates on your condition to discuss. Would it be all right if I shared these with you now?”).
  • If the patient does not want to know details, offer to answer any questions he or she may have in the future or to talk to a caregiver.
Knowledge

Giving knowledge and information to the patient

  • Consider a warning prior to disclosing bad news to the patient (i.e., “Unfortunately, I do not have good news” or “I’m sorry to tell you that…”).
  • Start at the level of comprehension and vocabulary of the patient.
  • Try to use nontechnical words and avoid medical jargon.
  • Avoid excessive bluntness.
  • Give information in small chunks, and periodically reassess the patient’s understanding.
  • When the prognosis is poor, avoid using phrases such as “There is nothing more we can do for you,” because patients may have other important therapeutic goals outside of curative therapy, such as good symptom relief.
Emotion

Addressing the patient’s emotions with empathic responses

  • Observe for any emotion on the part of the patient.
  • Identify the emotion experienced by the patient by naming it to oneself: use open‐ended questions to query the patient as to what he or she is feeling.
  • Identify the reason for the emotion—if you are not sure, ask the patient.
  • After you have given the patient time to express his or her feelings, show the patient that you recognize and empathize with his or her emotional response.
Strategy and summary

Presenting a clear plan for the future with the patient

  • Assess whether the patient needs clarification on what has been discussed.
  • Ask the patient if he or she is ready for a discussion regarding next steps in management.
  • Set out a medical plan of action.

Table 2.

Recommended Conversation Starters for Practitioners During ACP Discussions

Topics Conversation Starters
Patient perspectives
Level of detail
  • Are you a detail‐oriented learner or do you prefer a general overview and plan?
Learning style
  • Some people are visual learners while others process conversations best. Which learning approach suits you the best?
Values and fears
  • What is most important to you in life?
  • What aspect of health would need to be taken from you, for you to feel that living was worse than dying?
Education
  • Meeting for the first time about a new illness that you have been diagnosed with can be overwhelming.

  • We have created educational pamphlets we can provide for you, which can help guide our future discussions.

  • Our clinic communicates with your other health providers, so that we all know your wishes and details regarding your health.

Readiness
Readiness to discuss ACP and GCD
  • Very ill patients with cirrhosis cannot always make their own health care decisions. We like to talk about these things early on to understand what you value in case such a situation arises. How would you feel discussing how cirrhosis may affect you in the future?
Readiness to choose a surrogate
  • If you were to get very sick, is there anyone you trust to make medical decisions for you? Does this person know what is important to you?
Focus of care
  • Recently, you had a complication of cirrhosis and were quite unwell. I would like to explain how cirrhosis may affect you in the future.

  • It is important to understand how disease‐modifying treatments and symptom‐control therapies are used together during an illness.

Prognosis
Discuss in general terms
  • To make sure that both you and your family are prepared, I like to address both the best‐ and worst‐case scenarios regarding how your cirrhosis may progress. Can we talk about these now?
  • Some patients ask me how their cirrhosis will affect how long they live. Are you interested in this type of information?
Review cirrhosis
Disease complications
  • The investigations that we have done show that your disease has worsened. I would like to discuss how that affects what treatments and therapies are going to help you live the best‐quality life possible.
End‐of‐life wishes
  • What would be important to you in your last months of life?
  • Where would you prefer to die?
Resources
  • Many communities have additional supports for patients with medical, social, psychological, and spiritual needs. Would you be interested in learning about some of these resources?

Documentation
  • This depends on where the patient is located. Various websites describe local and regional Goals of Care Medical Orders.

Review and compare
  • Please tell me what you understand of your decisions with respect to your GCD. What impact do they have on your life? I want to ensure that the designation properly reflects your values and wishes.

  • Since we last met, have you had any experiences that may change your view about living with cirrhosis?

  • Are your wishes outlined anywhere else, such as in a Will or legal document? If so, we should look at it to ensure your wishes are consistent with your medical documents.

Reproduced with permission from Hepatology.19 Copyright 2018, American Association for the Study of Liver Diseases.

Physical and Psychological Symptom Management

Patients with ALD experience a great deal of physical and emotional suffering throughout the course of their illness and at the end of life.22 Although certain physical symptoms may be well managed by gastroenterologists and hepatologists, pain and mental health issues are often underrecognized.23 Peng et al.24 described the prevalence of physical and mental health symptoms in a recent systematic review (Table 3). Caregivers also report declines in their physical and mental health; this burden often increases steadily throughout a patient’s illness trajectory and is often unaddressed.25 A previous publication from Clinical Liver Disease contains a comprehensive review of pharmacological options and highlights challenges involved in pain management for patients with cirrhosis.26 Greater recognition of symptoms and caregiver issues in patients with ALD and their caregivers is needed, and referral to specialty palliative care services may be warranted in patients with complex pain management issues, history of opioid addiction, and management of spiritual and caregiver issues.

Table 3.

Symptom Prevalence in Patients With ESLD Compared With Other Chronic Conditions24

Symptom ESLD Cancer* COPD* CHF* ESRD* Dementia* MND* MS*
Pain 30‐79 30‐97 21‐77 14‐78 11‐83 14‐63 52‐76 68
Breathlessness 20‐88 16‐77 56‐98 18‐88 11‐82 12‐52 81‐88 26
Insomnia 26‐77 3‐67 15‐77 36‐48 1‐83 14 24‐33
Fatigue 52‐86 23‐100 32‐96 42‐82 13‐100 22 80
Anorexia 49 76‐95 64‐67 38‐64
Nausea or vomiting 58 2‐78 4 2‐48 8‐52 8 26
Depression 4.5‐64 4‐80 17‐77 6‐59 2‐61 46 23 15
Anxiety 14‐45 3‐74 23‐53 2‐49 7‐52 8‐72 19 24

Copyright 2019, European Association for Palliative Care, reproduced under CC‐BY‐NC.

*

Data on prevalence of symptoms. The values are given in percentage.

Summary

The following are tips for including palliative care in practice:

  • Ensure that physical symptoms, including pain, and mental health issues are being recognized and addressed.

  • Consider developing skill in performing ACP. This includes encouraging completion of advance directives.

  • Recognize caregiver burden and spiritual distress.

  • Invest in building relationships with specialty palliative care teams so that all dimensions of palliative care can be addressed.

This study was supported by the American Association for the Study of Liver Diseases Advanced/Transplant Hepatology Fellowship Award, UCLA Specialty Training and Advanced Research (to A.P.), and the National Institutes of Health grant T32DK007191 (to N.U.).

Potential conflict of interest: Nothing to report.

References

  • 1. D'Amico G, Garcia‐Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies. J Hepatol 2006;44:217‐231. [DOI] [PubMed] [Google Scholar]
  • 2. Marchesini G, Bianchi G, Amodio P, et al. Factors associated with poor health‐related quality of life of patients with cirrhosis. Gastroenterology 2001;120:170‐178. [DOI] [PubMed] [Google Scholar]
  • 3. Altekruse SF, Henley SJ, Cucinelli JE, et al. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Am J Gastroenterol 2014;109:542‐553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Schmidt ML, Barritt AS, Orman ES, et al. Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010. Gastroenterology 2015;148:967‐977.e2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. National Coalition for Hospice & Palliative Care . Clinical Practice Guidelines for Quality Palliative Care, 4th ed Richmond, VA: National Coalition for Hospice & Palliative Care; 2018. Available at: https://www. nationalcoalitionhpc.org/ncp . [Google Scholar]
  • 6. Quill TE, Abernethy AP. Generalist plus specialist palliative care—creating a more sustainable model. N Engl J Med 2013;368:1173‐1175. [DOI] [PubMed] [Google Scholar]
  • 7. Kavalieratos D, Corbelli J, Zhang D, et al. Association between palliative care and patient and caregiver outcomes: A systematic review and meta‐analysis. JAMA 2016;316:2104‐2114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Bakitas M, Lyons KD, Hegel MT, et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: The Project ENABLE II randomized controlled trial. JAMA 2009;302:741‐749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Baumann AJ, Wheeler DS, James M, et al. Benefit of early palliative care intervention in end‐stage liver disease patients awaiting liver transplantation. J Pain Symptom Manage 2015;50:882‐886.e2. [DOI] [PubMed] [Google Scholar]
  • 10. Patel AA, Walling AM, Ricks‐Oddie J, et al. Palliative care and health care utilization for patients with end‐stage liver disease at the end of life. Clin Gastroenterol Hepatol 2017;15:1612‐1619.e1614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Rush B, Walley KR, Celi LA, et al. Palliative care access for hospitalized patients with end‐stage liver disease across the United States. Hepatology 2017;66:1585‐1591. [DOI] [PubMed] [Google Scholar]
  • 12. Sudore RL, Lum HD, You JJ, et al. Defining advance care planning for adults: A consensus definition from a multidisciplinary delphi panel. J Pain Symptom Manage 2017;53:821‐832.e1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Brinkman‐Stoppelenburg A, Rietjens JA, van der Heide A. The effects of advance care planning on end‐of‐life care: A systematic review. Palliat Med 2014;28:1000‐1025. [DOI] [PubMed] [Google Scholar]
  • 14. Sprange A, Ismond KP, Hjartarson E, et al. Advance care planning preferences and readiness in cirrhosis: A prospective assessment of patient perceptions and knowledge. J Palliat Med; 10.1089/jpm.2019.0244. [DOI] [PubMed] [Google Scholar]
  • 15. Ufere NN, Donlan J, Waldman L, et al. Barriers to use of palliative care and advance care planning discussions for patients with end‐stage liver disease. Clin Gastroenterol Hepatol 2019;17:2592‐2599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Low J, Vickerstaff V, Davis S, et al. Palliative care for cirrhosis: A UK survey of health professionals’ perceptions, current practice and future needs. Frontline Gastroenterol 2016;7:4‐9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Walling AM, Ahluwalia SC, Wenger NS, et al. Palliative care quality indicators for patients with end‐stage liver disease due to cirrhosis. Dig Dis Sci 2017;62:84‐92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Baile WF, Buckman R, Lenzi R, et al. SPIKES—a six‐step protocol for delivering bad news: Application to the patient with cancer. Oncologist 2000;5:302‐311. [DOI] [PubMed] [Google Scholar]
  • 19. Brisebois A, Ismond KP, Carbonneau M, et al. Advance care planning (ACP) for specialists managing cirrhosis: A focus on patient‐centered care. Hepatology 2018;67:2025‐2040. [DOI] [PubMed] [Google Scholar]
  • 20. Jones CA, Acevedo J, Bull J, et al. Top 10 tips for using advance care planning codes in palliative medicine and beyond. J Palliat Med 2016;19:1249‐1253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Lamba S, Murphy P, McVicker S, et al. Changing end‐of‐life care practice for liver transplant service patients: Structured palliative care intervention in the surgical intensive care unit. J Pain Symptom Manage 2012;44:508‐519. [DOI] [PubMed] [Google Scholar]
  • 22. Roth K, Lynn J, Zhong Z, et al. Dying with end stage liver disease with cirrhosis: Insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. J Am Geriatr Soc 2000;48(Suppl. 5):S122‐S130. [PubMed] [Google Scholar]
  • 23. Hansen L, Leo MC, Chang MF, et al. Pain and self‐care behaviours in adult patients with end‐stage liver disease: A longitudinal description. J Palliat Care 2014;30:32‐40. [PMC free article] [PubMed] [Google Scholar]
  • 24. Peng JK, Hepgul N, Higginson IJ, et al. Symptom prevalence and quality of life of patients with end‐stage liver disease: A systematic review and meta‐analysis. Palliative Med 2019;33:24‐36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Bajaj JS, Wade JB, Gibson DP, et al. The multi‐dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol 2011;106:1646‐1653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Rakoski M, Goyal P, Spencer‐Safier M, et al. Pain management in patients with cirrhosis. Clin Liver Dis (Hoboken) 2018;11:135‐140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Parikh RB, Kirch RA, Smith TJ, et al. Early specialty palliative care--translating data in oncology into practice. N Engl J Med 2013;369:2347‐2351. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Liver Disease are provided here courtesy of American Association for the Study of Liver Diseases

RESOURCES